Weekly paclitaxel followed by 24 hour infusion high-dose 5-fluorouracil and leucovorin (T-HDFL) chemotherapy for hormone-refractory prostate cancer (HRPC).

被引：0
|
作者：
Lin, CC [1 ]
Hsu, CH [1 ]
Cheng, AL [1 ]
Guan, JY [1 ]
Huang, CY [1 ]
Chen, J [1 ]
Pu, YS [1 ]
机构：
[1] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4738
引用
收藏
页码：440S / 440S
页数：1
相关论文
共 50 条
  • [41] Phase II trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer
    Eckel, F
    Lersch, C
    Assmann, G
    Schulte-Frohlinde, E
    ANNALS OF ONCOLOGY, 2000, 11 (06) : 762 - 763
  • [42] RANDOMIZED PHASE II STUDY OF CISPLATIN AND HIGH-DOSE 5-FLUOROURACIL/LEUCOVORIN OR PACLITAXEL AND HIGH-DOSE 5-FLUOROURACIL/LEUCOVORIN IN LOCALLY ADVANCED OR METASTATIC GASTRIC CANCER AND ADENOCARCINOMAS OF THE GASTRO-OESOPHAGEAL JUNCTION
    Luelmo, S.
    Polee, M.
    van Bochove, A.
    Pruijt, H.
    Ouwerkerk, J.
    Sleeboom, H.
    Tesselaar, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 173 - 174
  • [43] Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma - An effective regimen with low toxicity
    Lin, CC
    Hsu, CH
    Huang, CY
    Cheng, AL
    Chen, J
    Vogelzang, NJ
    Pu, YS
    CANCER, 2006, 106 (06) : 1269 - 1275
  • [44] Mitoxantrone (MX), 5-fluorouracil (5-FU) and high dose levo-folinic acid (HD-LFA) in widely metastatic hormone-refractory prostate cancer (HRPC)
    Magarotto, R
    Nascimben, O
    Cirillo, M
    Picece, V
    Molon, A
    Pastorello, M
    Biason, R
    Recaldin, E
    ANNALS OF ONCOLOGY, 1998, 9 : 89 - 89
  • [45] Weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin in the treatment of advanced gastric cancers - An effective and low-toxic regimen for patients with poor general condition
    Hsu, CH
    Yeh, KH
    Chen, LT
    Liu, JM
    Jan, CM
    Lin, JT
    Chen, YC
    Cheng, AL
    ONCOLOGY, 1997, 54 (04) : 275 - 280
  • [46] HIGH-DOSE 24-HOUR INFUSION OF 5-FLUOROURACIL IN METASTATIC PROSTATE-CANCER - A PHASE-II TRIAL OF THE PIEDMONT ONCOLOGY ASSOCIATION
    ATKINS, JN
    MUSS, HB
    CASE, D
    BROCKSCHMIDT, J
    SCHNELL, FM
    OROURKE, M
    GROTE, TH
    WEST, JH
    ANTHONY, S
    STANLEY, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (06): : 526 - 529
  • [47] Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil
    K-H Yeh
    S-H Yeh
    C-H Hsu
    T-M Wang
    I-F Ma
    A-L Cheng
    British Journal of Cancer, 2000, 83 : 1510 - 1515
  • [48] Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil
    Yeh, KH
    Yeh, SH
    Hsu, CH
    Wang, TM
    Ma, IF
    Cheng, AL
    BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1510 - 1515
  • [49] Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma
    Lin, JC
    Jan, JS
    Chen, KY
    Hsu, CY
    Liang, WM
    Wang, WY
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (06): : 438 - 447
  • [50] Phase II study with cisplatin and paclitaxel in combination with weekly high-dose 24 h infusional 5-fluorouracil/leucovorin for first-line treatment of metastatic breast cancer
    Klaassen, U
    Wilke, H
    Weyhofen, R
    Harstrick, A
    Eberhardt, W
    Muller, C
    Korn, M
    Hanske, M
    Diergarten, K
    Seeber, S
    ANTI-CANCER DRUGS, 1998, 9 (03) : 203 - 207
12345